On May 31, 2023, Altamira Therapeutics Ltd., closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | -4.27% |
|
-7.44% | -67.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-67.82% | 2.51M | |
+16.73% | 121B | |
+21.13% | 114B | |
+18.05% | 23.61B | |
-17.94% | 20.43B | |
-16.24% | 16.55B | |
-11.76% | 16.45B | |
-44.45% | 15.59B | |
+69.92% | 15.19B | |
+1.41% | 13.54B |
- Stock Market
- Equities
- CYTO Stock
- News Altamira Therapeutics Ltd.
- Altamira Therapeutics Ltd. announced that it has received CHF 2.5 million in funding from FiveT Investment Management Ltd.